GlassScriptPhysician profile
Megan Smith
NPI 1598230492
$3,151.08
in general payments reported to CMS, 2019-2025
26 companies · $598 in 2025
The $598 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $495 · 2023: $692 · 2024: $1,201 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,354.29 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,222.13 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Janssen Pharmaceuticals, INC | $353.94 | 2021-2024 | Xarelto |
| Novo Nordisk INC | $274.14 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Medical Device Business Services, INC. | $227.01 | 2024 | Stratafix |
| Organogenesis INC. | $157.46 | 2021-2024 | Puraply Wound Matrix, Nushield, Novachor |
| Lilly USA, LLC | $101.81 | 2022-2024 | Zepbound |
| Smith+Nephew, INC. | $95.61 | 2021-2023 | Renasys Go V2 Home, Collagenase Santyl |
| Idorsia Pharmaceuticals US INC | $88.59 | 2023 | Quviviq |
| Reprise Biomedical, INC. | $82.79 | 2021-2024 | Miro3d |
| Amgen INC. | $78.12 | 2025 | Evenity |
| Aroa Biosurgery Incorporated | $68.23 | 2025 | |
| Lemaitre Vascular, INC. | $61.41 | 2024 | Trivex System, Artegraft Vascular Graft |
| Triad Life Sciences INC. | $44.54 | 2022 | |
| Medtronic, INC. | $35.76 | 2022-2023 | Closurefast |
| Kci USA, INC. | $33.64 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $33.43 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Urgo Medical North America, LLC | $29.94 | 2023 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Kowa Pharmaceuticals America, INC. | $27.68 | 2023 | Seglentis |
| Solventum Corporation | $25.84 | 2024 | Activ.A.C. |
| Bard Peripheral Vascular, INC. | $20.64 | 2021 | |
| Bioventus LLC | $18.55 | 2022 | |
| Pfizer INC. | $18.06 | 2023 | |
| Nabriva Therapeutics, Plc | $14.83 | 2022 | |
| Advanced Oxygen Therapy INC. | $14.29 | 2024 | Topical Oxygen Chamber For Extremities |
| Cordis US Corp. | $12.88 | 2023 | Brite Tip Radianz |
| Clarus Therapeutics INC. | $9.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.